Literature DB >> 15005957

The GAME estimate of reduced life expectancy.

Wilbert B van den Hout1.   

Abstract

The Declining Exponential Approximation of Life Expectancy (DEALE) is a simple method of estimating the impact of excess mortality on life expectancy, but it can lead to considerable bias due to the implicit constant baseline and excess mortality rates. This article presents a new method that does not use constant mortality rates. The variability of the baseline mortality is modeled using gamma (GA) distributions. Excess mortality rates are modeled using mixed-exponential (ME) distributions, which is appropriate if the excess mortality rate is nonincreasing, convex, and smooth. The new gamma mixed-exponential (GAME) estimate is convenient enough to replace the DEALE in formal decision analyses. The error from assuming gamma distributions for the Dutch baseline mortality was shown to be less than 2 months and typically about 1 month. Therefore, the GAME estimate is accurate enough to replace more elaborate methods, provided the mixed-exponential model is an appropriate model for the excess mortality.

Mesh:

Year:  2004        PMID: 15005957     DOI: 10.1177/0272989X03261564

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  3 in total

1.  Cost-effectiveness of cranberry capsules to prevent urinary tract infection in long-term care facilities: economic evaluation with a randomized controlled trial.

Authors:  Wilbert B van den Hout; Monique A A Caljouw; Hein Putter; Herman J M Cools; Jacobijn Gussekloo
Journal:  J Am Geriatr Soc       Date:  2014-01       Impact factor: 5.562

2.  A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension.

Authors:  Gudula J A M Boon; Wilbert B van den Hout; Stefano Barco; Harm Jan Bogaard; Marion Delcroix; Menno V Huisman; Stavros V Konstantinides; Lilian J Meijboom; Esther J Nossent; Petr Symersky; Anton Vonk Noordegraaf; Frederikus A Klok
Journal:  ERJ Open Res       Date:  2021-09-06

3.  Cost-utility analysis of genetic screening in families of patients with germline MUTYH mutations.

Authors:  Maartje Nielsen; Frederik J Hes; Hans F A Vasen; Wilbert B van den Hout
Journal:  BMC Med Genet       Date:  2007-07-02       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.